PLEASE NOTE: Legislative Information cannot perform research, provide legal advice, or interpret Maine law. For legal assistance, please contact a qualified attorney.
Amend the bill in section 1 in §1711-E in subsection 4 in paragraph D in the first line (page 2, line 35 in L.D.) by inserting after the following: "individual" the following: 'or the individual's health care provider'
Amend the bill in section 1 in §1711-E in subsection 4 in paragraph E in the first line (page 2, line 39 in L.D.) by striking out the following: "Transfers" and inserting the following: 'The transfer or use of prescription drug information'
Amend the bill in section 1 in §1711-E in subsection 4 in paragraph E in the last line (page 2, line 41 in L.D.) by striking out the following: "; and" and inserting the following: ';'
Amend the bill in section 1 in §1711-E in subsection 4 in paragraph F in the last line (page 3, line 2 in L.D.) by striking out the following: "prescriber." and inserting the following: 'prescriber; and'
Amend the bill in section 1 in §1711-E in subsection 4 by inserting after paragraph F the following:
 
‘G. The transfer or use of prescription drug information for a purpose listed in section 1711-C, subsection 6, paragraph B, paragraphs D to M and paragraph P, as long as the information is not used for a commercial purpose.’
 
SUMMARY
This amendment is the minority report of the committee. The amendment clarifies that prescriber information may be used for the following:
1. Care management communications to an individual's health care provider;
2. Pharmacy reimbursement, prior authorization and formulary compliance, patient care management, utilization review, health care research and transfers required by law; and
3. Noncommercial purposes for which disclosure is allowed under the Maine Revised Statutes, Title 22, section 1711-C, subsection 6, paragraph B, paragraphs D to M and paragraph P.
FISCAL NOTE REQUIRED
(See attached)